WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Friday, biopharmaceutical company AbbVie, Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2026, based on strong outlook and significant momentum.
For fiscal 2026, AbbVie now projects adjusted earnings in a range of $13.95 to $13.99 per share, up from the prior forecast range of $13.76 to $13.96 per share.
The company said the guidance includes an unfavorable impact of $0.69 per share related to acquired IPR&D and milestones expense incurred year-to-date through the third quarter 2026.
AbbVie is also announcing that its board of directors declared a 5.2 percent higher quarterly cash dividend of $1.82 per share beginning with the dividend payable on February 16, 2027 to shareholders of record as of January 15, 2027.
In Friday's pre-market trading, ABBV is trading on the NYSE at $292.00, up $1.11 or 0.38 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
